Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow RENOVARO INC.

Get SEC filing alerts via email and in your feed for RENOVARO INC.

RENB

RENOVARO INC.

About RENOVARO INC.

Renovaro Inc. is a biotechnology company focused on developing advanced cell and gene therapies for cancer and infectious diseases, aiming for long-term remission and cures. Its subsidiaries, Renovaro Biosciences and Renovaro Cube, leverage proprietary AI and multi-omics platforms for early cancer detection, recurrence monitoring, and personalized diagnostics. The company combines innovative therapeutics with precision diagnostics to improve patient outcomes and reduce healthcare costs.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from RENOVARO INC.

1
1
RENOVARO INC. Lunai Bioworks Reports Service Revenue Growth and Reduced Net Loss in Latest Financial Results

Via official filing (AI summary) | 19 days ago | 0 comments

2
1
RENOVARO INC. Lunai Bioworks Reports 75% Improvement in Quarterly Net Loss, Achieves $1M Net Income for Six Months

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
RENOVARO INC. Lunai Bioworks Reports Net Income Turnaround and Strategic Changes in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
RENOVARO INC. Lunai Bioworks Reports $178 Million Net Loss and Faces Financial Challenges

Via official filing (AI summary) | 8 months ago | 0 comments

5
1
RENOVARO INC. Renovaro Inc. Reports Significant Financial Challenges, Net Loss Increases 382% in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments